Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclon...
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
About this item
Full title
Author / Creator
Tian, Xiaolong , Li, Cheng , Huang, Ailing , Xia, Shuai , Lu, Sicong , Shi, Zhengli , Lu, Lu , Jiang, Shibo , Yang, Zhenlin , Wu, Yanling and Ying, Tianlei
Publisher
United States: Taylor & Francis
Journal title
Language
English
Formats
Publication information
Publisher
United States: Taylor & Francis
Subjects
More information
Scope and Contents
Contents
The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity of receptor-binding domain (RBD) in 2019-nCoV and...
Alternative Titles
Full title
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_32065055
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32065055
Other Identifiers
ISSN
2222-1751
E-ISSN
2222-1751
DOI
10.1080/22221751.2020.1729069
